Physician profile
Timothy M Kitchen
NPI 1003884289
$2,319.49
in general payments reported to CMS, 2019-2025
19 companies · $186 in 2025
The $186 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $77.07 · 2020: $46.35 · 2021: $50.89 · 2022: $123 · 2023: $1,488 · 2024: $348 · 2025: $186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,217 · Travel and Lodging: $805.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,216.97 |
| Travel and Lodging | $805.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $1,246.57 | 2022-2023 | |
| Novo Nordisk INC | $322.24 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Lilly USA, LLC | $147.00 | 2019-2025 | Jardiance, Zepbound, Mounjaro |
| Biomarin Pharmaceutical INC. | $131.26 | 2023-2024 | Palynziq |
| Boston Scientific Corporation | $71.89 | 2023-2025 | Watchman Flx, Watchman Access System |
| Astrazeneca Pharmaceuticals LP | $67.61 | 2022-2025 | Farxiga, Airsupra |
| Merck Sharp & Dohme LLC | $66.72 | 2024-2025 | Capvaxive, Gardasil 9, Gardasil |
| Pfizer INC. | $55.59 | 2023-2024 | |
| Abbott Laboratories | $33.56 | 2019-2025 | Freestyle Libre 3 |
| Sanofi-Aventis U.S. LLC | $30.93 | 2020-2022 | |
| Exact Sciences Corporation | $26.94 | 2024 | Cologuard Collection Kit |
| Abbvie INC. | $22.15 | 2024 | |
| Astellas Pharma US INC | $20.67 | 2024 | Veozah |
| Xeris Pharmaceuticals, INC. | $20.54 | 2025 | Keveyis |
| Amgen INC. | $19.90 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $19.68 | 2023 | Arexvy, Shingrix |
| Biohaven Pharmaceutical Holding Company LTD. | $16.24 | 2022 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Kitchen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.